Neuropathy, Fibromyalgia & Chronic Pain Conditions (8)
Peripheral neuropathy, sciatica, fibromyalgia, trigeminal neuralgia, and non-opioid pain management.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Neuropathy, Fibromyalgia & Chronic Pain Guides (8)
Clear All Filters ×Meralgia paresthetica, unspecified lower limb
Designated in federal medical registries as G57.10, Meralgia paresthetica, unspecified lower limb falls under Chronic Pain & Nerves management, where quantitative sensory examination [Meralgia paresthetica, unspecified lower limb G57.10] establishes baseline severity and rules out diagnostic mimics.
Mononeuritis multiplex
Designated in federal medical registries as G58.7, Mononeuritis multiplex falls under Chronic Pain & Nerves management, where multimodal non-opioid neuromodulation [Mononeuritis multiplex G58.7] establishes baseline severity and rules out diagnostic mimics.
Mononeuropathy
Physicians managing Mononeuropathy (G58.9; Neuropathy, Fibromyalgia & Chronic Pain) utilize multimodal non-opioid neuromodulation [Mononeuropathy G58.9] and objective HbA1c & 2-Hour in Mononeuropathy (G58.9: Glucose Tolerance) targets (HbA1c < 5.6% (G58.9)) to prevent progression and functional morbidity.
Muscle aches (myalgia)
Muscle aches (myalgia) (also termed Myalgia)—coded clinically as M79.10 across Chronic Pain & Nerves guidelines—combines multimodal non-opioid neuromodulation [Muscle aches (myalgia) M79.10] with structured follow-up of hs-CRP & ESR in Muscle aches (myalgia) (M79.10: Inflammatory Check) (hs-CRP < 1.0 mg/L (M79.10)).
Myalgia of auxiliary muscles, head and neck
Designated in federal medical registries as M79.12, Myalgia of auxiliary muscles, head and neck falls under Chronic Pain & Nerves management, where metabolic/autoimmune neuropathy lab in Myalgia of auxiliary muscles, head and neck (M79.12: panels) establishes baseline severity and rules out diagnostic mimics.
Myalgia of mastication muscle
Within Neuropathy, Fibromyalgia & Chronic Pain practice, Myalgia of mastication muscle (ICD-10 M79.11) is stratified through multimodal non-opioid neuromodulation [Myalgia of mastication muscle M79.11], pairing targeted symptom control with longitudinal HbA1c & 2-Hour in Myalgia of mastication muscle (M79.11: Glucose Tolerance) surveillance.
Myalgia, other site
Physicians managing Myalgia, other site (M79.18; Neuropathy, Fibromyalgia & Chronic Pain) utilize metabolic/autoimmune neuropathy lab in Myalgia, other site (M79.18: panels) and objective HbA1c & 2-Hour in Myalgia, other site (M79.18: Glucose Tolerance) targets (HbA1c < 5.6% (M79.18)) to prevent progression and functional morbidity.
Myalgia, unspecified site
Within Neuropathy, Fibromyalgia & Chronic Pain practice, Myalgia, unspecified site (ICD-10 M79.10) is stratified through physical desensitization therapy [Myalgia, unspecified site M79.10], pairing targeted symptom control with longitudinal Vitamin B12 & in Myalgia, unspecified site (M79.10: Methylmalonic Acid) surveillance.